Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr 1;3(3):52-55.
doi: 10.1002/cld.320. eCollection 2014 Mar.

Diagnosis and management of patients with primary biliary cirrhosis

Jessica Dyson  1 , David Jones  2
Affiliations

Diagnosis and management of patients with primary biliary cirrhosis

Jessica Dyson et al. Clin Liver Dis (Hoboken). .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Immunofluorescence patterns in ANAs. Representative AMA and ANA indirect immunofluorescence staining patterns are shown: AMA staining in (A) a rat liver, (B) the Hep2 cell line, (C) rat gastric parietal cells, and (D) a rat kidney; ANA staining in (E) homogeneous nuclear and (F) nuclear rimlike patterns in the Hep2 cell line; and peripheral staining in (G) the Hep2 cell line and (H) rat liver cells.
Figure 2
Figure 2
Biopsy images: PBC versus predominant AIH. (A) Destructive cholangitis (arrow) and mild mixed portal inflammatory infiltrate with focal interface activity (arrowheads) in PBC (hematoxylin and eosin, ×10). The inset shows characteristic granulomatous cholangitis and a dense lymphoplasmacytic infiltrate involving another portal tract (hematoxylin and eosin, ×20). (B) Autoimmune cholangiopathy with features suggestive of overlap with AIH. This indicates that steroid use may be appropriately considered: moderate, predominantly plasmacytic, chronic inflammation in the portal tract and focal lymphocytic cholangitis (white arrows) with mild degenerative changes in the interlobular bile duct epithelium; moderate interface activity (white arrowheads) including plasma cells; and zone 1 spotty necrosis (black arrow; hematoxylin and eosin, ×20). The inset shows evidence of chronic cholestasis with dark brown intracytoplasmic granules of copper‐associated protein in periportal hepatocytes (black arrowheads; orcein, ×40).
Figure 3
Figure 3
Flowchart providing simple guidance for the diagnosis of PBC.
Figure 4
Figure 4
Factors contributing to fatigue in PBC.
See this image and copyright information in PMC

References

    1. Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, et al. A sensitive bead assay for antimitochondrial antibodies: chipping away at AMA‐negative primary biliary cirrhosis. Hepatology 2007;45:659‐665. - PubMed
    1. Metcalf JV, Mitchison HC, Palmer JM, Jones DE, Bassendine MF, James OF. Natural history of early primary biliary cirrhosis. Lancet 1996;348:1399‐1402. - PubMed
    1. Worman HJ, Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2003;2:211‐217. - PubMed
    1. Wesierska‐Gadek J, Penner E, Battezzati PM, Selmi C, Zuin M, Hitchman E, et al. Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis. Hepatology 2006;43:1135‐1144. - PubMed
    1. Zein CO, Angulo P, Lindor KD. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? Clin Gastroenterol Hepatol 2003;1:89‐95. - PubMed